| Canagliflozin |
| (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol |
| (CAS 842133-18-0) |
 |
| Description： |
Canagliflozin(JNJ 28431754; TA 7284) is a highly potent and selective SGLT2 inhibitor for hSGLT2 with IC50 of 2.2 nM, exhibits 413-fold selectivity over hSGLT1.
IC50 value: 2.2 nM
Target: SGLT2
Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an experimental drug being developed by Johnson & Johnson for the treatment of type 2 diabetes.Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine.
|
| Product No. |
KT20200 |
| Product Name |
Canagliflozin |
| Synonyms |
JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284 |
| Formal Name |
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol |
| CAS Number |
842133-18-0 |
| Molecular Formula |
C24H25FO5S |
| Formula Weight |
444.52 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
SGLT2 inhibitor
Canagliflozin hemihydrate
Dapagliflozin
Dapagliflozin(2S)-1,2-propanediol,hydrate
Empagliflozin
Ipragliflozin
LX-4211
PF-04971729
Phloretin
Phlorizin
|
|
